<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Ra Pharmaceuticals, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Ra Pharmaceuticals, Inc.

    Ra PharmaÂŽ is a clinical-stage biopharmaceutical company using a proprietary peptide chemistry platform to develop novel therapeutics for the treatment of serious diseases that are caused by excessive or uncontrolled activation of the complement system, a critical component of the immune system. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Douglas Treco, Ph.D.
    • FOUNDED
      2008
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    GenMark Diagnostics, Inc.

    GenMark Diagnostics, Inc.

    GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of multiplex molecular di...

    GenMark Diagnostics (NASDAQ: GNMK) is a leading...

    Filing Type:    PU
    Oracle Health, Inc.

    Oracle Health, Inc.

    Oracle Health is developing a Digital Health Insertable (Under The Skin) Cardiac D...

    Oracle Health is developing a Digital Health In...

    Amount Raised:    $182,002.00
    Fundraising Status:    EC
    Filing Type:    CF
    Celgene Corporation

    Celgene Corporation

    Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global ...

    Celgene Corporation, headquartered in Summit, N...

    Filing Type:    PU
    Organogenesis Holdings Inc.

    Organogenesis Holdings Inc.

    Organogenesis Holdings Inc. is a leading regenerative medicine company focused on ...

    Organogenesis Holdings Inc. is a leading regene...

    Filing Type:    PU
    Stoke Therapeutics, Inc.

    Stoke Therapeutics, Inc.

    Stoke is pioneering a new way to treat the underlying cause of severe genetic dise...

    Stoke is pioneering a new way to treat the unde...

    Filing Type:    PU
    Acceleron Pharma Inc.

    Acceleron Pharma Inc.

    Acceleron is dedicated to the discovery and development of innovative, life-changi...

    Acceleron is dedicated to the discovery and dev...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.